Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"

Affiliations

• ¹ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ² Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians University, Munich, Germany.
• ³ Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
• ⁴ University of Montpellier, INSERM U1194 IRCM, Institut du Cancer Montpellier (ICM), Montpellier, France.
• ⁵ Patient advocate, Hasselt, Belgium.
• ⁶ University of Manchester, Manchester, UK.
• ⁷ Federation Universitaire d'Oncologie Radiothérapie d'Occitanie Méditerranée, Institut du Cancer Du Gard (ICG), CHU Carémeau, Nîmes, France.
• ⁸ Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
• ⁹ Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
• ¹⁰ Istituto Nazionale dei Tumori, Data Science Unit, Milan, Italy.
• ¹¹ University of Leicester, Leicester, UK.
• ¹² Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ¹³ Maastro Clinic, Maastricht, The Netherlands.
• ¹⁴ KU Leuven, Leuven, Belgium.
• ¹⁵ Universitätsmedizin Mannheim, Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
• ¹⁶ Independent Cancer Patients' Voice, London, UK.
• ¹⁷ Biomedical Network on Rare Diseases (CIBERER), Seville, Spain.
• ¹⁸ Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
• ¹⁹ Ghent University Hospital, Ghent, Belgium.
• ²⁰ Ghent University, Ghent, Belgium.
• ²¹ NCRI CTRad Consumer, London, UK.
• ²² University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.